Repligen CorpRGEN
Price$177.23Intrinsic value$46.5274% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $738.3M+16.4% YoYTTM through 31 Dec 2025
Net Income $48.9MTTM through 31 Dec 2025
Free Cash Flow $91.7MTTM through 31 Dec 2025

Margins

Current
Gross Margin52.3%
Operating Margin7.5%
Net Margin6.6%

Returns

2.3%ROE
1.7%ROA
2.3%ROIC

Balance Sheet Health

Debt / Equity0.26x
Current Ratio8.37x
Net Debt-$225.4Mnet cash position
Cash & Equivalents$566M

Quality Metrics

FCF Margin12.4%
Rule of 4024.4
Earnings-Beat Rate75.0%

Dividend

No dividend

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.